Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.

Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected ...

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes ...

Gastric Cancer Prevention: New AGA Update Reflects Latest High-Risk Screening and Surveillance Advice. Carolyn Crist. May 02, 2025 . 0. Clinicians can help reduce gastric cancer incidence and ...

S tomach cancer (medically known as gastric cancer) is a major health issue worldwide. In the United States, stomach cancer is the third most common malignancy related to dietary habits. Having an ...

According to Astellas, an estimated 130,263 people in the U.S. are living with gastric or GEJ cancer, which places it among the rarer cancers. CLDN18.2 is found only in stomach cells, ...

The American Cancer Society’s estimates for stomach cancer in the U.S. for 2024 are: About 26,890 new cases of stomach cancer (16,160 in men and 10,730 in women) About 10,880 deaths from this ...

The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's website showed on Friday.

Stomach cancer of the upper stomach and the esophagus has been rising dramatically. They're both starting with obesity. But we don't really understand why it's going up rapidly," Dr. Chak said.